The most recent case in 2020 involved multiple bone and bone marrow metastases from a 1p/19q-codeleted and IDH2-mutant oligodendroglioma, WHO grade 3, confirmed by MLPA studies [11]. This evidence concerns the gene IDH2 and oligodendroglioma.